{
    "id": "pathfinder_tests",
    "name": "pathfinder_tests",
    "description": "Pathfinder tests",
    "tags": [],
    "test_runner_settings": [],
    "test_metadata": {
        "id": "1",
        "name": null,
        "description": "Pathfinder tests",
        "tags": [],
        "test_runner_settings": [],
        "test_source": "SMURF",
        "test_reference": null,
        "test_objective": "AcceptanceTest",
        "test_annotations": []
    },
    "test_persona": "All",
    "test_cases": {
        "TestCase_0": {
            "id": "TestCase_0",
            "name": "PTFQ_1a",
            "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_2",
                    "name": "PTFQ_1a.1: Imatinib to Asthma, through KIT",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004979",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_3",
                    "name": "PTFQ_1a.2: Imatinib to Asthma, through Histamine",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004979",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:18295",
                                "PR:000049994"
                            ],
                            "name": "Histamine"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_4",
                    "name": "PTFQ_1a.3: Imatinib to Asthma, through SCF-1",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004979",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4254"
                            ],
                            "name": "SCF-1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_5",
                    "name": "PTFQ_1a.4: Imatinib to Asthma, through Mast Cell",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004979",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000097"
                            ],
                            "name": "Mast Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_1",
                    "name": "PTFQ_1a: Imatinib to Asthma",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004979",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        },
                        {
                            "ids": [
                                "CHEBI:18295",
                                "PR:000049994"
                            ],
                            "name": "Histamine"
                        },
                        {
                            "ids": [
                                "NCBIGene:4254"
                            ],
                            "name": "SCF-1"
                        },
                        {
                            "ids": [
                                "CL:0000097"
                            ],
                            "name": "Mast Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_1": {
            "id": "TestCase_1",
            "name": "PTFQ_4",
            "description": "A GWAS study suggests that a variant in gene SLC6A20 may be associated with susceptibility to COVID19. What could be the molecular mechanism(s) that explain(s) this connection ?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_26",
                    "name": "PTFQ_4.2: SLC6A20 to COVID-19, NFE2L2",
                    "description": "A GWAS study suggests that a variant in gene SLC6A20 may be associated with susceptibility to COVID19. What could be the molecular mechanism(s) that explain(s) this connection ?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:54716",
                    "source_input_name": "SLC6A20",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4780"
                            ],
                            "name": "NFE2L2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_27",
                    "name": "PTFQ_4.3: SLC6A20 to COVID-19, SARAS-Cov2 - Spike-protein",
                    "description": "A GWAS study suggests that a variant in gene SLC6A20 may be associated with susceptibility to COVID19. What could be the molecular mechanism(s) that explain(s) this connection ?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:54716",
                    "source_input_name": "SLC6A20",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "UniProtKB:P0DTC2"
                            ],
                            "name": "SARAS-Cov2 - Spike-protein"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_24",
                    "name": "PTFQ_4: SLC6A20 to COVID-19",
                    "description": "A GWAS study suggests that a variant in gene SLC6A20 may be associated with susceptibility to COVID19. What could be the molecular mechanism(s) that explain(s) this connection ?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:54716",
                    "source_input_name": "SLC6A20",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:59272"
                            ],
                            "name": "ACE2"
                        },
                        {
                            "ids": [
                                "NCBIGene:4780"
                            ],
                            "name": "NFE2L2"
                        },
                        {
                            "ids": [
                                "UniProtKB:P0DTC2"
                            ],
                            "name": "SARAS-Cov2 - Spike-protein"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_25",
                    "name": "PTFQ_4.1: SLC6A20 to COVID-19, ACE2",
                    "description": "A GWAS study suggests that a variant in gene SLC6A20 may be associated with susceptibility to COVID19. What could be the molecular mechanism(s) that explain(s) this connection ?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:54716",
                    "source_input_name": "SLC6A20",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:59272"
                            ],
                            "name": "ACE2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_2": {
            "id": "TestCase_2",
            "name": "PTFQ_8",
            "description": "Fluxetine has been widely touted as a possible treatment for the psychic symptoms of LONG-COVID. Many mechanism have neen proposed. Could the Translator retrieve them without the literature summaries?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_71",
                    "name": "PTFQ_8.1: Fluoxetine (Prozac) to long-COVID, IFNG",
                    "description": "Fluxetine has been widely touted as a possible treatment for the psychic symptoms of LONG-COVID. Many mechanism have neen proposed. Could the Translator retrieve them without the literature summaries?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:5118",
                    "source_input_name": "Fluoxetine (Prozac)",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0100233",
                    "target_input_name": "long-COVID",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3458"
                            ],
                            "name": "IFNG"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_70",
                    "name": "PTFQ_8: Fluoxetine (Prozac) to long-COVID",
                    "description": "Fluxetine has been widely touted as a possible treatment for the psychic symptoms of LONG-COVID. Many mechanism have neen proposed. Could the Translator retrieve them without the literature summaries?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:5118",
                    "source_input_name": "Fluoxetine (Prozac)",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0100233",
                    "target_input_name": "long-COVID",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3458"
                            ],
                            "name": "IFNG"
                        },
                        {
                            "ids": [
                                "CHEBI:50949"
                            ],
                            "name": "SSRI agonist"
                        },
                        {
                            "ids": [
                                "NCBIGene:10280"
                            ],
                            "name": "SIGMAR1"
                        },
                        {
                            "ids": [
                                "NCBIGene:856478",
                                "NCBIGene:856478"
                            ],
                            "name": "IRE1"
                        },
                        {
                            "ids": [
                                "UBERON:0001759"
                            ],
                            "name": "vagus nerve"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_75",
                    "name": "PTFQ_8.5: Fluoxetine (Prozac) to long-COVID, vagus nerve",
                    "description": "Fluxetine has been widely touted as a possible treatment for the psychic symptoms of LONG-COVID. Many mechanism have neen proposed. Could the Translator retrieve them without the literature summaries?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:5118",
                    "source_input_name": "Fluoxetine (Prozac)",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0100233",
                    "target_input_name": "long-COVID",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "UBERON:0001759"
                            ],
                            "name": "vagus nerve"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_74",
                    "name": "PTFQ_8.4: Fluoxetine (Prozac) to long-COVID, IRE1",
                    "description": "Fluxetine has been widely touted as a possible treatment for the psychic symptoms of LONG-COVID. Many mechanism have neen proposed. Could the Translator retrieve them without the literature summaries?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:5118",
                    "source_input_name": "Fluoxetine (Prozac)",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0100233",
                    "target_input_name": "long-COVID",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:856478",
                                "NCBIGene:856478"
                            ],
                            "name": "IRE1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_73",
                    "name": "PTFQ_8.3: Fluoxetine (Prozac) to long-COVID, SIGMAR1",
                    "description": "Fluxetine has been widely touted as a possible treatment for the psychic symptoms of LONG-COVID. Many mechanism have neen proposed. Could the Translator retrieve them without the literature summaries?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:5118",
                    "source_input_name": "Fluoxetine (Prozac)",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0100233",
                    "target_input_name": "long-COVID",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:10280"
                            ],
                            "name": "SIGMAR1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_72",
                    "name": "PTFQ_8.2: Fluoxetine (Prozac) to long-COVID, SSRI agonist",
                    "description": "Fluxetine has been widely touted as a possible treatment for the psychic symptoms of LONG-COVID. Many mechanism have neen proposed. Could the Translator retrieve them without the literature summaries?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:5118",
                    "source_input_name": "Fluoxetine (Prozac)",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0100233",
                    "target_input_name": "long-COVID",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:50949"
                            ],
                            "name": "SSRI agonist"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_3": {
            "id": "TestCase_3",
            "name": "PTFQ_7b",
            "description": "How does aspirin help prevent colorectal cancer?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_67",
                    "name": "PTFQ_7b.4: Aspirin to Colorectal Cancer, prostaglandin PGE2",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:15365",
                    "source_input_name": "Aspirin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:26333",
                                "CHEBI:176067",
                                "CHEBI:15551"
                            ],
                            "name": "prostaglandin PGE2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_66",
                    "name": "PTFQ_7b.3: Aspirin to Colorectal Cancer, resolvins",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:15365",
                    "source_input_name": "Aspirin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:132120",
                                "UMLS:C4288292"
                            ],
                            "name": "resolvins"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_63",
                    "name": "PTFQ_7b: Aspirin to Colorectal Cancer",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:15365",
                    "source_input_name": "Aspirin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4513"
                            ],
                            "name": "COX2"
                        },
                        {
                            "ids": [
                                "NCBIGene:4791",
                                "NCBIGene:4790"
                            ],
                            "name": "NFKB"
                        },
                        {
                            "ids": [
                                "CHEBI:132120",
                                "UMLS:C4288292"
                            ],
                            "name": "resolvins"
                        },
                        {
                            "ids": [
                                "CHEBI:26333",
                                "CHEBI:176067",
                                "CHEBI:15551"
                            ],
                            "name": "prostaglandin PGE2"
                        },
                        {
                            "ids": [
                                "UniProtKB:P43246-1",
                                "UniProtKB:P43246-2"
                            ],
                            "name": "hMSH2"
                        },
                        {
                            "ids": [
                                "UniProtKB:P40692-2",
                                "UniProtKB:P40692-3",
                                "UniProtKB:P40692-1"
                            ],
                            "name": "hMLH1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_65",
                    "name": "PTFQ_7b.2: Aspirin to Colorectal Cancer, NFKB",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:15365",
                    "source_input_name": "Aspirin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4791",
                                "NCBIGene:4790"
                            ],
                            "name": "NFKB"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_69",
                    "name": "PTFQ_7b.6: Aspirin to Colorectal Cancer, hMLH1",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:15365",
                    "source_input_name": "Aspirin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "UniProtKB:P40692-2",
                                "UniProtKB:P40692-3",
                                "UniProtKB:P40692-1"
                            ],
                            "name": "hMLH1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_68",
                    "name": "PTFQ_7b.5: Aspirin to Colorectal Cancer, hMSH2",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:15365",
                    "source_input_name": "Aspirin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "UniProtKB:P43246-1",
                                "UniProtKB:P43246-2"
                            ],
                            "name": "hMSH2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_64",
                    "name": "PTFQ_7b.1: Aspirin to Colorectal Cancer, COX2",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:15365",
                    "source_input_name": "Aspirin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4513"
                            ],
                            "name": "COX2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_4": {
            "id": "TestCase_4",
            "name": "PTFQ_10",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_88",
                    "name": "PTFQ_10: Warfarin to Cancer Neoplasia",
                    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:10033",
                    "source_input_name": "Warfarin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004992",
                    "target_input_name": "Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:79001"
                            ],
                            "name": "VKORC1"
                        },
                        {
                            "ids": [
                                "MESH:C021527"
                            ],
                            "name": "vitamin K oxidoreductase"
                        },
                        {
                            "ids": [
                                "NCBIGene:558"
                            ],
                            "name": "AXL"
                        },
                        {
                            "ids": [
                                "NCBIGene:2621"
                            ],
                            "name": "GAS6"
                        },
                        {
                            "ids": [
                                "CHEBI:28384"
                            ],
                            "name": "Vitamin K"
                        },
                        {
                            "ids": [
                                "GO:0001837, GO:0010717"
                            ],
                            "name": "Epthelial-to-Mesenchymal -transition"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_92",
                    "name": "PTFQ_10.4: Warfarin to Cancer Neoplasia, GAS6",
                    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:10033",
                    "source_input_name": "Warfarin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004992",
                    "target_input_name": "Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:2621"
                            ],
                            "name": "GAS6"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_93",
                    "name": "PTFQ_10.5: Warfarin to Cancer Neoplasia, Vitamin K",
                    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:10033",
                    "source_input_name": "Warfarin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004992",
                    "target_input_name": "Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:28384"
                            ],
                            "name": "Vitamin K"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_89",
                    "name": "PTFQ_10.1: Warfarin to Cancer Neoplasia, VKORC1",
                    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:10033",
                    "source_input_name": "Warfarin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004992",
                    "target_input_name": "Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:79001"
                            ],
                            "name": "VKORC1"
                        },
                        {
                            "ids": [
                                "MESH:C021527"
                            ],
                            "name": "vitamin K oxidoreductase"
                        },
                        {
                            "ids": [
                                "NCBIGene:558"
                            ],
                            "name": "AXL"
                        },
                        {
                            "ids": [
                                "NCBIGene:2621"
                            ],
                            "name": "GAS6"
                        },
                        {
                            "ids": [
                                "CHEBI:28384"
                            ],
                            "name": "Vitamin K"
                        },
                        {
                            "ids": [
                                "GO:0001837, GO:0010717"
                            ],
                            "name": "Epthelial-to-Mesenchymal -transition"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_94",
                    "name": "PTFQ_10.6: Warfarin to Cancer Neoplasia, Epthelial-to-Mesenchymal -transition",
                    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:10033",
                    "source_input_name": "Warfarin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004992",
                    "target_input_name": "Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "GO:0001837, GO:0010717"
                            ],
                            "name": "Epthelial-to-Mesenchymal -transition"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_90",
                    "name": "PTFQ_10.2: Warfarin to Cancer Neoplasia, vitamin K oxidoreductase",
                    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:10033",
                    "source_input_name": "Warfarin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004992",
                    "target_input_name": "Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "MESH:C021527"
                            ],
                            "name": "vitamin K oxidoreductase"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_91",
                    "name": "PTFQ_10.3: Warfarin to Cancer Neoplasia, AXL",
                    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:10033",
                    "source_input_name": "Warfarin",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004992",
                    "target_input_name": "Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:558"
                            ],
                            "name": "AXL"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_5": {
            "id": "TestCase_5",
            "name": "PTFQ_5a",
            "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_30",
                    "name": "PTFQ_5a.2: IFNG to COVID-19, IFNGR",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3459",
                                "NCBIGene:3460"
                            ],
                            "name": "IFNGR"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_31",
                    "name": "PTFQ_5a.3: IFNG to COVID-19, kyurenine",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:16946"
                            ],
                            "name": "kynurenine"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_34",
                    "name": "PTFQ_5a.6: IFNG to COVID-19, IDO2",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:169355"
                            ],
                            "name": "IDO2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_35",
                    "name": "PTFQ_5a.7: IFNG to COVID-19, aryl hydrocarbon receptor",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "PR:000003858",
                                "UniProtKB:P35869"
                            ],
                            "name": "aryl hydrocarbon receptor"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_32",
                    "name": "PTFQ_5a.4: IFNG to COVID-19, T Cell",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000084"
                            ],
                            "name": "T Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_29",
                    "name": "PTFQ_5a.1: IFNG to COVID-19, IDO1",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3620"
                            ],
                            "name": "IDO1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_33",
                    "name": "PTFQ_5a.5: IFNG to COVID-19, Regulator T Cell",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "MONDO:0100096",
                    "target_input_name": "COVID-19",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000815"
                            ],
                            "name": "Regulator T Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_6": {
            "id": "TestCase_6",
            "name": "PTFQ_5c",
            "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_47",
                    "name": "PTFQ_5c.3: IFNG to tryptophan N-allylamide, kyurenine",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptophan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:16946"
                            ],
                            "name": "kynurenine"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_51",
                    "name": "PTFQ_5c.7: IFNG to tryptophan N-allylamide, aryl hydrocarbon receptor",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptophan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "PR:000003858",
                                "UniProtKB:P35869"
                            ],
                            "name": "aryl hydrocarbon receptor"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_50",
                    "name": "PTFQ_5c.6: IFNG to tryptophan N-allylamide, IDO2",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptohphan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:169355"
                            ],
                            "name": "IDO2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_46",
                    "name": "PTFQ_5c.2: IFNG to tryptophan N-allylamide, IFNGR",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptophan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3459",
                                "NCBIGene:3460"
                            ],
                            "name": "IFNGR"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_49",
                    "name": "PTFQ_5c.5: IFNG to tryptophan N-allylamide, Regulator T Cell",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptohphan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000815"
                            ],
                            "name": "Regulator T Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_45",
                    "name": "PTFQ_5c.1: IFNG to tryptophan N-allylamide, IDO1",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptophan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3620"
                            ],
                            "name": "IDO1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_44",
                    "name": "PTFQ_5c: IFNG to tryptophan N-allylamide",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptophan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3620"
                            ],
                            "name": "IDO1"
                        },
                        {
                            "ids": [
                                "NCBIGene:3459",
                                "NCBIGene:3460"
                            ],
                            "name": "IFNGR"
                        },
                        {
                            "ids": [
                                "CHEBI:16946"
                            ],
                            "name": "kynurenine"
                        },
                        {
                            "ids": [
                                "CL:0000084"
                            ],
                            "name": "T cell"
                        },
                        {
                            "ids": [
                                "CL:0000815"
                            ],
                            "name": "Regulator T cell"
                        },
                        {
                            "ids": [
                                "NCBIGene:169355"
                            ],
                            "name": "IDO2"
                        },
                        {
                            "ids": [
                                "PR:000003858",
                                "UniProtKB:P35869"
                            ],
                            "name": "aryl hydrocarbon receptor"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_48",
                    "name": "PTFQ_5c.4: IFNG to tryptophan N-allylamide, T Cell",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "PUBCHEM.COMPOUND:22691495",
                    "target_input_name": "tryptophan N-allylamide",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000084"
                            ],
                            "name": "T Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_7": {
            "id": "TestCase_7",
            "name": "PTFQ_1b",
            "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_10",
                    "name": "PTFQ_1b.4: Imatinib to Allergic Asthma, Mast Cell",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004784",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000097"
                            ],
                            "name": "Mast Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_8",
                    "name": "PTFQ_1b.2: Imatinib to Allergic Asthma, Histamine",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004784",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:18295",
                                "PR:000049994"
                            ],
                            "name": "Histamine"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_9",
                    "name": "PTFQ_1b.3: Imatinib to Allergic Asthma, SCF-1",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004784",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4254"
                            ],
                            "name": "SCF-1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_6",
                    "name": "IPTFQ_1b: Imatinib to Allergic Asthma",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004784",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        },
                        {
                            "ids": [
                                "CHEBI:18295",
                                "PR:000049994"
                            ],
                            "name": "Histamine"
                        },
                        {
                            "ids": [
                                "NCBIGene:4254"
                            ],
                            "name": "SCF-1"
                        },
                        {
                            "ids": [
                                "CL:0000097"
                            ],
                            "name": "Mast Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_7",
                    "name": "PTFQ_1b.1: Imatinib to Allergic Asthma, KIT",
                    "description": "The kinase inhibitor imatinib is used to treat cancers. Why does it also show efficacy in the treatment of severe asthma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45783",
                    "source_input_name": "Imatinib",
                    "source_input_category": "biolink:Drug",
                    "target_input_id": "MONDO:0004784",
                    "target_input_name": "Asthma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_8": {
            "id": "TestCase_8",
            "name": "PTFQ_9",
            "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_84",
                    "name": "PTFQ_9.8: Parkinson's Disease to melanoma, UCHL1",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:7345"
                            ],
                            "name": "UCHL1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_85",
                    "name": "PTFQ_9.9: Parkinson's Disease to melanoma, TRPM7",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:54822"
                            ],
                            "name": "TRPM7"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_82",
                    "name": "PTFQ_9.6: Parkinson's Disease to melanoma, PLA2G6",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:8398"
                            ],
                            "name": "PLA2G6"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_77",
                    "name": "PTFQ_9.1: Parkinson's Disease to melanoma, PRKN",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:5071"
                            ],
                            "name": "PRKN"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_76",
                    "name": "PTFQ_9: Parkinson's Disease to melanoma",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:5071"
                            ],
                            "name": "PRKN"
                        },
                        {
                            "ids": [
                                "NCBIGene:6622"
                            ],
                            "name": "SNCA"
                        },
                        {
                            "ids": [
                                "NCBIGene:120892"
                            ],
                            "name": "LRRK2"
                        },
                        {
                            "ids": [
                                "NCBIGene:11315"
                            ],
                            "name": "PARK7"
                        },
                        {
                            "ids": [
                                "NCBIGene:65018"
                            ],
                            "name": "PINK1"
                        },
                        {
                            "ids": [
                                "NCBIGene:8398"
                            ],
                            "name": "PLA2G6"
                        },
                        {
                            "ids": [
                                "NCBIGene:27429"
                            ],
                            "name": "HTRA2"
                        },
                        {
                            "ids": [
                                "NCBIGene:7345"
                            ],
                            "name": "UCHL1"
                        },
                        {
                            "ids": [
                                "NCBIGene:54822"
                            ],
                            "name": "TRPM7"
                        },
                        {
                            "ids": [
                                "NCBIGene:4157"
                            ],
                            "name": "MC1R"
                        },
                        {
                            "ids": [
                                "MONDO:0100471"
                            ],
                            "name": "Vitamin D Deficiency"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_83",
                    "name": "PTFQ_9.7: Parkinson's Disease to melanoma, HTRA2",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:27429"
                            ],
                            "name": "HTRA2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_80",
                    "name": "PTFQ_9.4: Parkinson's Disease to melanoma, PARK7",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:11315"
                            ],
                            "name": "PARK7"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_79",
                    "name": "PTFQ_9.3: Parkinson's Disease to melanoma, LRRK2",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:120892"
                            ],
                            "name": "LRRK2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_78",
                    "name": "PTFQ_9.2: Parkinson's Disease to melanoma, SNCA",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:6622"
                            ],
                            "name": "SNCA"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_81",
                    "name": "PTFQ_9.5: Parkinson's Disease to melanoma, PINK1",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:65018"
                            ],
                            "name": "PINK1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_86",
                    "name": "PTFQ_9.10: Parkinson's Disease to melanoma, MC1R",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4157"
                            ],
                            "name": "MC1R"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_87",
                    "name": "PTFQ_9.11: Parkinson's Disease to melanoma, Vitamin D Deficiency",
                    "description": "Why do patients with Parkinson's disease have a markedly higher tendency to develop melanoma?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "MONDO:0005180",
                    "source_input_name": "Parkinson's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "MONDO:0005105",
                    "target_input_name": "melanoma",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "MONDO:0100471"
                            ],
                            "name": "Vitamin D Deficiency"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_9": {
            "id": "TestCase_9",
            "name": "PTFQ2a",
            "description": "How does resveratrol affect glyoxalase?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_11",
                    "name": "PTFQ2a",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45713",
                    "source_input_name": "trans-resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        },
                        {
                            "ids": [
                                "NCBIGene:855009"
                            ],
                            "name": "GLO1"
                        },
                        {
                            "ids": [
                                "GO:0034599"
                            ],
                            "name": "Cellular response to oxidative stress"
                        },
                        {
                            "ids": [
                                "UMLS:C5543862",
                                "NCBIGene:84900"
                            ],
                            "name": "NFT2 pathway"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_14",
                    "name": "PTFQ2a.3",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45713",
                    "source_input_name": "trans-resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "GO:0034599"
                            ],
                            "name": "Cellular response to oxidative stress"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_15",
                    "name": "PTFQ2a.4",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45713",
                    "source_input_name": "trans-resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "UMLS:C5543862",
                                "NCBIGene:84900"
                            ],
                            "name": "NFT2 pathway"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_12",
                    "name": "PTFQ2a.1",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45713",
                    "source_input_name": "trans-resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_13",
                    "name": "PTFQ2a.2",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:45713",
                    "source_input_name": "trans-resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:855009"
                            ],
                            "name": "GLO1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_10": {
            "id": "TestCase_10",
            "name": "PTFQ_5b",
            "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_41",
                    "name": "PTFQ_5b.5: IFNG to tryptophan, Regulator T Cell",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptohphan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000815"
                            ],
                            "name": "Regulator T Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_36",
                    "name": "PTFQ_5b: IFNG to tryptophan",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptophan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3620"
                            ],
                            "name": "IDO1"
                        },
                        {
                            "ids": [
                                "NCBIGene:3459",
                                "NCBIGene:3460"
                            ],
                            "name": "IFNGR"
                        },
                        {
                            "ids": [
                                "CHEBI:16946"
                            ],
                            "name": "kynurenine"
                        },
                        {
                            "ids": [
                                "CL:0000084"
                            ],
                            "name": "T cell"
                        },
                        {
                            "ids": [
                                "CL:0000815"
                            ],
                            "name": "Regulator T cell"
                        },
                        {
                            "ids": [
                                "NCBIGene:169355"
                            ],
                            "name": "IDO2"
                        },
                        {
                            "ids": [
                                "PR:000003858",
                                "UniProtKB:P35869"
                            ],
                            "name": "aryl hydrocarbon receptor"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_37",
                    "name": "PTFQ_5b.1: IFNG to tryptophan, IDO1",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptophan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3620"
                            ],
                            "name": "IDO1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_40",
                    "name": "PTFQ_5b.4: IFNG to tryptophan, T Cell",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptophan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CL:0000084"
                            ],
                            "name": "T Cell"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_38",
                    "name": "PTFQ_5b.2: IFNG to tryptophan, IFNGR",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptophan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3459",
                                "NCBIGene:3460"
                            ],
                            "name": "IFNGR"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_43",
                    "name": "PTFQ_5b.7: IFNG to tryptophan, aryl hydrocarbon receptor",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptophan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "PR:000003858",
                                "UniProtKB:P35869"
                            ],
                            "name": "aryl hydrocarbon receptor"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_42",
                    "name": "PTFQ_5b.6: IFNG to tryptophan, IDO2",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptohphan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:169355"
                            ],
                            "name": "IDO2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_39",
                    "name": "PTFQ_5b.3: IFNG to tryptophan, kyurenine",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptophan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:16946"
                            ],
                            "name": "kynurenine"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_28",
                    "name": "PTFQ_5a: IFNG to tryptophan",
                    "description": "What pathway explains why serum IFN-g and tryptophane are generally anticorrelated - but even more so in COVID-19 patients, when IFN-g is elevated?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "NCBIGene:3458",
                    "source_input_name": "IFNG",
                    "source_input_category": "biolink:Gene",
                    "target_input_id": "CHEBI:16828",
                    "target_input_name": "tryptophan",
                    "target_input_category": "biolink:SmallMolecule",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3620"
                            ],
                            "name": "IDO1"
                        },
                        {
                            "ids": [
                                "NCBIGene:3459",
                                "NCBIGene:3460"
                            ],
                            "name": "IFNGR"
                        },
                        {
                            "ids": [
                                "CHEBI:16946"
                            ],
                            "name": "kynurenine"
                        },
                        {
                            "ids": [
                                "CL:0000084"
                            ],
                            "name": "T cell"
                        },
                        {
                            "ids": [
                                "CL:0000815"
                            ],
                            "name": "Regulator T cell"
                        },
                        {
                            "ids": [
                                "NCBIGene:169355"
                            ],
                            "name": "IDO2"
                        },
                        {
                            "ids": [
                                "PR:000003858",
                                "UniProtKB:P35869"
                            ],
                            "name": "aryl hydrocarbon receptor"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_11": {
            "id": "TestCase_11",
            "name": "PTFQ2b",
            "description": "How does resveratrol affect glyoxalase?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_16",
                    "name": "PTFQ2b",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        },
                        {
                            "ids": [
                                "NCBIGene:855009"
                            ],
                            "name": "GLO1"
                        },
                        {
                            "ids": [
                                "GO:0034599"
                            ],
                            "name": "Cellular response to oxidative stress"
                        },
                        {
                            "ids": [
                                "UMLS:C5543862",
                                "NCBIGene:84900"
                            ],
                            "name": "NFT2 pathway"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_20",
                    "name": "PTFQ2b.4",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "UMLS:C5543862",
                                "NCBIGene:84900"
                            ],
                            "name": "NFT2 pathway"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_21",
                    "name": "PTFQ3",
                    "description": "In some rare families, Crohn's disease and Parkinson's disease co-occur. Is there a possible genetic link between these two apparently distinct conditions?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "Crohn's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "Parkinson's Disease",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:11315"
                            ],
                            "name": "PARK7"
                        },
                        {
                            "ids": [
                                "NCBIGene:120892"
                            ],
                            "name": "LRRK2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_17",
                    "name": "PTFQ2b.1",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:3815"
                            ],
                            "name": "KIT"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_22",
                    "name": "PTFQ3.1",
                    "description": "In some rare families, Crohn's disease and Parkinson's disease co-occur. Is there a possible genetic link between these two apparently distinct conditions?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "Crohn's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "Parkinson's Disease",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:11315"
                            ],
                            "name": "PARK7"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_18",
                    "name": "PTFQ2b.2",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:855009"
                            ],
                            "name": "GLO1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_19",
                    "name": "PTFQ2b.3",
                    "description": "How does resveratrol affect glyoxalase?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "resveratrol",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "glyoxalase",
                    "target_input_category": "biolink:Gene",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "GO:0034599"
                            ],
                            "name": "Cellular response to oxidative stress"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_23",
                    "name": "PTFQ3.2",
                    "description": "In some rare families, Crohn's disease and Parkinson's disease co-occur. Is there a possible genetic link between these two apparently distinct conditions?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:27881",
                    "source_input_name": "Crohn's Disease",
                    "source_input_category": "biolink:Disease",
                    "target_input_id": "NCBIGene:2739",
                    "target_input_name": "Parkinson's Disease",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:120892"
                            ],
                            "name": "LRRK2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_12": {
            "id": "TestCase_12",
            "name": "PTFQ_7a",
            "description": "How does aspirin help prevent colorectal cancer?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_57",
                    "name": "PTFQ_7a.1: Acetylsalicylate to Colorectal Cancer, COX2",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:13719",
                    "source_input_name": "Acetylsalicylate",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4513"
                            ],
                            "name": "COX2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_61",
                    "name": "PTFQ_7a.5: Acetylsalicylate to Colorectal Cancer, hMSH2",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:13719",
                    "source_input_name": "Acetylsalicylate",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "UniProtKB:P43246-1",
                                "UniProtKB:P43246-2"
                            ],
                            "name": "hMSH2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_60",
                    "name": "PTFQ_7a.4: Acetylsalicylate to Colorectal Cancer, prostaglandin PGE2",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:13719",
                    "source_input_name": "Acetylsalicylate",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:26333",
                                "CHEBI:176067",
                                "CHEBI:15551"
                            ],
                            "name": "prostaglandin PGE2"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_56",
                    "name": "PTFQ_7a: Acetylsalicylate to Colorectal Cancer",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:13719",
                    "source_input_name": "Acetylsalicylate",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4513"
                            ],
                            "name": "COX2"
                        },
                        {
                            "ids": [
                                "NCBIGene:4791",
                                "NCBIGene:4790"
                            ],
                            "name": "NFKB"
                        },
                        {
                            "ids": [
                                "CHEBI:132120",
                                "UMLS:C4288292"
                            ],
                            "name": "resolvins"
                        },
                        {
                            "ids": [
                                "CHEBI:26333",
                                "CHEBI:176067",
                                "CHEBI:15551"
                            ],
                            "name": "prostaglandin PGE2"
                        },
                        {
                            "ids": [
                                "UniProtKB:P43246-1",
                                "UniProtKB:P43246-2"
                            ],
                            "name": "hMSH2"
                        },
                        {
                            "ids": [
                                "UniProtKB:P40692-2",
                                "UniProtKB:P40692-3",
                                "UniProtKB:P40692-1"
                            ],
                            "name": "hMLH1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_59",
                    "name": "PTFQ_7a.3: Acetylsalicylate to Colorectal Cancer, resolvins",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:13719",
                    "source_input_name": "Acetylsalicylate",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "CHEBI:132120",
                                "UMLS:C4288292"
                            ],
                            "name": "resolvins"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_58",
                    "name": "PTFQ_7a.2: Acetylsalicylate to Colorectal Cancer, NFKB",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:13719",
                    "source_input_name": "Acetylsalicylate",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:4791",
                                "NCBIGene:4790"
                            ],
                            "name": "NFKB"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_62",
                    "name": "PTFQ_7a.6: Acetylsalicylate to Colorectal Cancer, hMLH1",
                    "description": "How does aspirin help prevent colorectal cancer?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:13719",
                    "source_input_name": "Acetylsalicylate",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0005575",
                    "target_input_name": "Colorectal Cancer",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "UniProtKB:P40692-2",
                                "UniProtKB:P40692-3",
                                "UniProtKB:P40692-1"
                            ],
                            "name": "hMLH1"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_13": {
            "id": "TestCase_13",
            "name": "Pentose",
            "description": "This is the start and end compound from KEGG pathway M00004, with a random compound from the pathway required to be an intermediate.",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_98",
                    "name": "Pentose phosphate pathway (Pentose phosphate cycle)",
                    "description": "This is the start and end compound from KEGG pathway M00004, with a random compound from the pathway required to be an intermediate.",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "KEGG.COMPOUND:C01172",
                    "source_input_name": "beta-D-Glucose 6-phosphate",
                    "source_input_category": "biolink:ChemicalEntity",
                    "target_input_id": "KEGG.COMPOUND:C00668",
                    "target_input_name": "alpha-D-Glucose 6-phosphate",
                    "target_input_category": "biolink:ChemicalEntity",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "KEGG.COMPOUND:C00117"
                            ],
                            "name": "D-Ribose 5-phosphate"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_14": {
            "id": "TestCase_14",
            "name": "Glycolysis",
            "description": "This is the start and end compound from KEGG pathway M00001, with a random compound from the pathway required to be an intermediate.",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_95",
                    "name": "Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate",
                    "description": "This is the start and end compound from KEGG pathway M00001, with a random compound from the pathway required to be an intermediate.",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "KEGG.COMPOUND:C00267",
                    "source_input_name": "alpha-D-Glucose",
                    "source_input_category": "biolink:ChemicalEntity",
                    "target_input_id": "KEGG.COMPOUND:C00022",
                    "target_input_name": "Pyruvate",
                    "target_input_category": "biolink:ChemicalEntity",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "KEGG.COMPOUND:C00197"
                            ],
                            "name": "3-Phospho-D-glycerate"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_15": {
            "id": "TestCase_15",
            "name": "Glycolysis,",
            "description": "This is the start and end compound from KEGG pathway M00002, with a random compound from the pathway required to be an intermediate.",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_96",
                    "name": "Glycolysis, core module involving three-carbon compounds",
                    "description": "This is the start and end compound from KEGG pathway M00002, with a random compound from the pathway required to be an intermediate.",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "KEGG.COMPOUND:C00111",
                    "source_input_name": "Glycerone phosphate",
                    "source_input_category": "biolink:ChemicalEntity",
                    "target_input_id": "KEGG.COMPOUND:C00022",
                    "target_input_name": "Pyruvate",
                    "target_input_category": "biolink:ChemicalEntity",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "KEGG.COMPOUND:C00197"
                            ],
                            "name": "3-Phospho-D-glycerate"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_16": {
            "id": "TestCase_16",
            "name": "PTFQ_6",
            "description": "What is the mechanism behind the hypothesis (now in clinical trial) that Viagra (and other ED drugs of same class) may slow senile dementia?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_55",
                    "name": "PTFQ_6.3: Sildenafil to Alzheimer's disease, vasodilation",
                    "description": "What is the mechanism behind the hypothesis (now in clinical trial) that Viagra (and other ED drugs of same class) may slow senile dementia?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:9139",
                    "source_input_name": "Sildenafil",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004975",
                    "target_input_name": "Alzheimer's disease",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "GO:0042311"
                            ],
                            "name": "vasodilation"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_54",
                    "name": "PTFQ_6.2: Sildenafil to Alzheimer's disease, cGMP",
                    "description": "What is the mechanism behind the hypothesis (now in clinical trial) that Viagra (and other ED drugs of same class) may slow senile dementia?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:9139",
                    "source_input_name": "Sildenafil",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004975",
                    "target_input_name": "Alzheimer's disease",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "GO:0004692",
                                "GO:0006182",
                                "GO:0019934",
                                "GO:0030553",
                                "GO:0046068",
                                "GO:0046069",
                                "GO:0070731",
                                "UniProtKB:Q13237-1"
                            ],
                            "name": "cGMP"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_53",
                    "name": "PTFQ_6.1: Sildenafil to Alzheimer's disease, PDE5A",
                    "description": "What is the mechanism behind the hypothesis (now in clinical trial) that Viagra (and other ED drugs of same class) may slow senile dementia?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:9139",
                    "source_input_name": "Sildenafil",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004975",
                    "target_input_name": "Alzheimer's disease",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:8654"
                            ],
                            "name": "PDE5A"
                        }
                    ],
                    "expected_output": "TopAnswer"
                },
                {
                    "id": "Asset_52",
                    "name": "PTFQ_6: Sildenafil to Alzheimer's disease",
                    "description": "What is the mechanism behind the hypothesis (now in clinical trial) that Viagra (and other ED drugs of same class) may slow senile dementia?",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "CHEBI:9139",
                    "source_input_name": "Sildenafil",
                    "source_input_category": "biolink:SmallMolecule",
                    "target_input_id": "MONDO:0004975",
                    "target_input_name": "Alzheimer's disease",
                    "target_input_category": "biolink:Disease",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 2,
                    "path_nodes": [
                        {
                            "ids": [
                                "NCBIGene:8654"
                            ],
                            "name": "PDE5A"
                        },
                        {
                            "ids": [
                                "GO:0004692",
                                "GO:0006182",
                                "GO:0019934",
                                "GO:0030553",
                                "GO:0046068",
                                "GO:0046069",
                                "GO:0070731",
                                "UniProtKB:Q13237-1"
                            ],
                            "name": "cGMP"
                        },
                        {
                            "ids": [
                                "GO:0042311"
                            ],
                            "name": "vasodilation"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        },
        "TestCase_17": {
            "id": "TestCase_17",
            "name": "Gluconeogenesis,",
            "description": "This is the start and end compound from KEGG pathway M00003, with a random compound from the pathway required to be an intermediate.",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "test_assets": [
                {
                    "id": "Asset_97",
                    "name": "Gluconeogenesis, oxaloacetate => fructose-6P",
                    "description": "This is the start and end compound from KEGG pathway M00003, with a random compound from the pathway required to be an intermediate.",
                    "tags": [],
                    "test_runner_settings": [
                        "pathfinder"
                    ],
                    "source_input_id": "KEGG.COMPOUND:C00036",
                    "source_input_name": "Oxaloacetate",
                    "source_input_category": "biolink:ChemicalEntity",
                    "target_input_id": "KEGG.COMPOUND:C00085",
                    "target_input_name": "D-Fructose 6-phosphate",
                    "target_input_category": "biolink:ChemicalEntity",
                    "predicate_id": "biolink:related_to",
                    "predicate_name": "related to",
                    "qualifiers": null,
                    "minimum_required_path_nodes": 1,
                    "path_nodes": [
                        {
                            "ids": [
                                "KEGG.COMPOUND:C00236"
                            ],
                            "name": "3-Phospho-D-glyceroyl phosphate"
                        }
                    ],
                    "expected_output": "TopAnswer"
                }
            ],
            "test_case_objective": "AcceptanceTest",
            "components": [
                "ars"
            ],
            "test_env": "ci"
        }
    },
    "test_suite_specification": null
}